zanamivir
J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AH - Neuraminidase Inhibitors -> J05AH01 - Zanamivir
Administration category:
Free
Medicine group:
antiviral
Brand name:
Dectova
Safety margins
| Weight | ROA | Dosage | |
|---|---|---|---|
|
ROA: iv |
Dosage: 600mg 2 dd |
||
|
Comments:
Gedurende 5 dagen |
|||
Kidney function
| ROA | GFR | Dosage | Interval | Comments |
|---|---|---|---|---|
| ROA: iv | ||||
|
GFR: 50 - 80 |
Dosage: startdosis 600 mg, na 12 uur gevolgd door 400 mg 2 dd |
|||
|
GFR: 30 - 50 |
Dosage: startdosis 600 mg, na 12 uur gevolgd door 250 mg 2 dd |
|||
|
GFR: 10 - 30 |
Dosage: startdosis 600 mg, na 24 uur gevolgd door 150 mg 2 dd |
|||
|
GFR: <10 |
Dosage: startdosis 600 mg, na 48 uur gevolgd door 60 mg 2 dd |
|||
Renal elimination:
100%
Dosage:
independent on kidney function
Renal function-replacement therapy
CAPD: iv: gebruik vermijden vanwege het ontbreken van gegevens
Hemo dialysis: iv: startdosis 600 mg, na 48 uur gevolgd door 60 mg 2 dd, op dialysedagen 1 dosis na de dialyse
CAV / VVHD: iv: oplaaddosis 600 mg, na 24 uur gevolgd door 150 mg 2 dd
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-500391.1
Updated: 09/15/2021 - 12:06
Status: Published